Braze, Inc. (NASDAQ:BRZE) Chief Financial Officer Isabelle Winkles sold 8,274 shares of the company’s Class A common stock on April 6, 2026, generating approximately $192,866 in proceeds. The reported sales were executed at prices between $23.07 and $23.95, according to a Form 4 filing submitted to the Securities and Exchange Commission.
Per the filing, the dispositions were made under a Rule 10b5-1 trading plan that Winkles adopted on January 2, 2026. After the sale, Winkles is recorded as directly owning 462,518 shares of Braze.
The insider transaction comes as the stock has moved lower. At the time of reporting, Braze shares were trading at $21.47, representing a 37% year-to-date decline. Analyzes referenced in available commentary indicate a split view: InvestingPro metrics suggest the stock appears undervalued on Fair Value measures, while 14 analysts have pared back earnings expectations in recent revisions.
Alongside the insider sale, Braze disclosed several other items that have drawn investor attention. Susan Wiseman, who serves as general counsel and secretary, has notified the company of her intention to retire by June 30, 2026.
On the research front, Raymond James reiterated an Outperform rating and raised its price target from $25 to $27, citing strong fourth-quarter bookings and accelerated revenue growth as supporting factors. Piper Sandler trimmed its price objective to $27 from $30, attributing the cut to a software sector de-rating while maintaining an Overweight rating. UBS also lowered its target to $28 from $43 but retained a Buy rating, noting Braze’s robust bookings performance and a fiscal 2027 revenue guidance that management says exceeds consensus expectations.
Financially, Braze reported a third consecutive quarter of accelerating organic revenue growth, with year-over-year expansion near 24% for the period described in company reports. These operational and analyst developments together outline a complex picture of performance and market perception as the company navigates its current trajectory.
Summary
The CFO’s Rule 10b5-1-guided sale and the company’s mixed analyst readouts coincide with a substantial year-to-date decline in the stock price, even as management emphasizes accelerating bookings and above-consensus revenue guidance for fiscal 2027. Leadership changes and analyst target adjustments contribute to investor focus on both near-term valuation and forward growth.